Warning! OUTDATED BROWSER DETECTED!   Please update your browser immediately for a better experience on this website. Learn More
21/xsl/MobileMenu.xsltmobileNave880e1541/WorkArea//http://www.rsna.org/RSNANewsDetailWireframe.aspx?pageid=15319&id=23343&ekfxmen_noscript=1&ekfxmensel=falsefalsetruetruetruefalsefalse10-18.0.0.0730truefalse
  •  
     
  • Your Donations in Action



    January 1, 2018

    Researcher Investigates New Modality for Treating Hepatocellular Carcinoma

    2017 RSNA Research Scholar Grant recipient Rahul Sheth, MD, will investigate a novel molecularly targeted photothermal ablation (MTPA) modality for the treatment of hepatocellular carcinoma (HCC).

    Building on the research he conducted with his 2013 Cook Medical Cesare Gianturco/RSNA Research Resident Grant, Dr. Sheth, along with his scientific advisor Erik Cressman, MD, PhD, hopes to catalyze an adaptive immune response to HCC.

    Dr. Sheth also anticipates that MTPA, due to its tumor specificity, will avoid damage to adjacent critical structures such as bile ducts. “If successful, MTPA could be combined synergistically with immunotherapies to provide a potent systemic treatment for patients with HCC,” said Dr. Sheth, assistant professor at the University of Texas MD Anderson Cancer Center, in Houston.




    Sheth
    Rahul Sheth, MD




    To:
    From:
    Subject:
    Comment:
    Link:
      
  •  
    comments powered by Disqus